NU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NU is a reasonable long-term hold, but not a clear buy right now for a beginner investor with $50,000-$100,000 who does not want to wait for a better entry. The stock has supportive growth and sentiment from a fresh Buy initiation at $17, but recent analyst downgrades and margin concerns offset that. At $13.575, it is near short-term resistance and momentum is stretched, so I would not call it a strong buy at this exact moment.
NU is in a short-term positive trend: the MACD histogram is positive and expanding, which supports upside momentum. However, RSI_6 is very high at 79.887, indicating the stock is extended even though the model labels it neutral. Moving averages are converging, suggesting the trend is not yet cleanly confirmed for a fresh long entry. Price closed at 13.575, just below R1 at 13.692 and above pivot 13.042, so the stock is trading near immediate resistance rather than at an attractive breakout or pullback level. The near-term pattern outlook is mildly bullish, but not ideal for an impatient buyer.
["Needham initiated coverage with a Buy rating and a $17 price target.", "Nubank is the primary financial institution for about 30% of Brazil's population, with 31.5 million people banked, supporting a large growth runway.", "Options sentiment is bullish, with call-heavy positioning.", "MACD momentum is positive and expanding.", "The company continues to benefit from strong financial inclusion and customer growth in Latin America."]
["Citi downgraded the stock to Neutral with a $13 target, citing growth at the expense of monetization and profitability.", "BofA downgraded to Underperform with a $10 target due to CFO departure and uncertainty around credit quality and expansion.", "Susquehanna downgraded to Neutral and highlighted margin pressure from credit card expansion and regional investment.", "RSI is stretched, suggesting the stock may be extended in the short term.", "Price is close to resistance, limiting immediate upside from current levels."]
No full financial snapshot was provided, so latest-quarter revenue or earnings figures cannot be assessed directly. From the available analyst commentary, the latest quarter appears to have shown growth but with margin pressure: Susquehanna noted operating margins fell 760 basis points to 19.2% in Q1 due to credit card expansion in Brazil and investment in Mexico. That indicates strong expansion, but profitability is under pressure in the latest reported quarter season.
Analyst sentiment is mixed but still slightly constructive overall. Recent actions include a new Buy initiation from Needham at $17 and earlier Buy/Outperform views from UBS and CICC, but these were offset by multiple downgrades: Citi to Neutral at $13, Susquehanna to Neutral at $13, and BofA to Underperform at $10. The Wall Street pros view sees a massive customer base, strong growth potential, and regional expansion upside; the cons view focuses on weaker monetization, margin compression, credit risk, and leadership uncertainty. Overall, analysts are divided, with the latest tone turning more cautious even though long-term growth bulls remain active.
